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The proper pathfinding and target recognition of an axon requires the precisely choreographed expression of a multitude of
guidance factors: instructive and permissive, positive and negative, and secreted and membrane bound. We show here that
the transcription factor LOLA is required for pathfinding and targeting of the SNb motor nerve in Drosophila. We also show
that lola is a dose-dependent regulator of SNb development: by varying the expression of one lola isoform we can
progressively titrate the extent of interaction of SNb motor axons with their target muscles, from no interaction at all,
through wild-type patterning, to apparent hyperinnervation. The phenotypes we observe from altered expression of LOLA
suggest that this protein may help orchestrate the coordinated expression of the genes required for faithful SNb
development. © 1999 Academic PressKey Words: axon guidance; synapse specification; alternative splicing; transcription factor; cell adhesion.
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1INTRODUCTION
As an axon projects toward its synaptic targets in vivo, it
ncounters a series of guidance “choice points,” at each of
hich the axon can either continue growing, turn onto a
ifferent substratum, or stop and form a synapse. It is
enerally believed that at each of these choice points the
xonal growth cone integrates signals from a large number
f guidance cues, including both attractive and repulsive
actors, both diffusible and membrane-bound (Bixby et al.,
987; Dodd and Jessell, 1988; Tessier-Lavigne and Good-
an, 1996; Winberg et al., 1998a). This view of axon
uidance, however, introduces its own complexity: what
echanism orchestrates the expression of the very precise
onstellation of guidance cues, receptors, and signaling
roteins required to specify a particular guidance choice
Daston and Koester, 1996)? The magnitude of the problem
s best illustrated by considering a particularly well-studied
xample of axon targeting, the pathfinding and target
ecognition performed by axons of the SNb motor nerve of
he Drosophila embryo.
1 To whom correspondence should be addressed at Fred Hutchin-
son Cancer Research Center, 1100 Fairview Ave, N., P.O. Box
19024, Seattle, WA 98109-1024. Fax: (206) 667-3308. E-mail:
eginiger@fhcrc.org.
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All rights of reproduction in any form reserved.In each embryonic abdominal hemisegment, the motor
ascicle of SNb (also known as ISNb) comprises the axons of
ight identified motoneurons that project dorsally out of
he ventral nerve cord, along a reproducible trajectory, to
ield a precise pattern of innervation of seven bodywall
uscles: the four ventral longitudinal muscles and the
hree most dorsal of the ventral oblique muscles (Sink and
hitington, 1991; Landgraf et al., 1997; diagrammed sche-
atically in Fig. 1H). Genetic studies have to date identi-
ed at least 13 different cell surface and secreted proteins
hose pattern and level of expression contribute to the
aithful pathfinding of SNb motor axons and to the selec-
ion of their appropriate synaptic targets (Van Vactor et al.,
993; Lin and Goodman, 1994; Nose et al., 1994; Chiba et
l., 1995; Matthes et al., 1995; Fambrough and Goodman,
996; Desai et al., 1997; Rose et al., 1997; Shishido et al.,
998; Winberg et al., 1998a, b; Yu et al., 1998). Molecular
data potentially implicate a number of additional cell
surface proteins in these processes, as well.
Several proteins have been shown to play precise, instruc-
tive roles in defining the synaptic choices of particular SNb
motoneurons. For example, recognition of muscles 6 and 7
by the RP3 motoneuron derives in part from expression of
the chemoattractant Netrin B by these two muscles and
presumably also from expression of the Netrin receptor in
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302 Madden, Crowner, and Ginigerthe RP3 growth cone (Mitchell et al., 1996; Winberg et al.,
1998a). Additional specificity of RP3 targetting is provided
by the homophilic interactions of Fasciclin 3 protein, which
is present both on the RP3 growth cone and on its two
target muscles, but not on neighboring muscles (Chiba et
al., 1995). Similarly, the protein Capricious is expressed
both in muscle 12 and in its innervating motoneuron RP5,
and this complementary pattern of expression is required
for faithful selection of muscle 12 by the RP5 growth cone
(Shishido et al., 1998).
In addition to these very specific, localized proteins, there
is a substantial list of cell surface proteins that are more
widely expressed and seem to play essentially permissive
roles in SNb targetting. For example, the Fasciclin 2 protein
is expressed on all motor axons and seems to contribute to
axon–axon adhesion (Lin and Goodman, 1994). Overex-
pressing Fasciclin 2 in SNb motoneurons prevents SNb
axons from entering the ventral muscle field or from
properly interacting with their intermediate and final tar-
gets, apparently due to excessively high levels of Fasciclin
2-mediated axon–axon adhesion. The deleterious effect of
increased Fasciclin 2 can be counteracted, however, by
increased expression of any of a variety of anti-adhesive
axonal proteins, such as the secreted protein Beat (Fam-
brough and Goodman, 1996; Winberg et al., 1998a). Con-
versely, if axon–axon adhesion is reduced too much, then
individual axons interact inappropriately with muscles
they would normally ignore (Van Vactor et al., 1993;
ambrough and Goodman, 1996; Winberg et al., 1998a; Yu
t al., 1998). Thus, it appears that specificity of innervation
s achieved, in part, by establishing a threshold of interac-
ion which approaching axons must attain with their pro-
pective targets in order to overcome a variety of nonspe-
ific negative influences (Matthes et al., 1995; Desai et al.,
997).
It appears that reliable neuromuscular recognition re-
uires a delicate balance of competing positive and negative
actors (Fambrough and Goodman, 1996; Desai et al., 1997;
inberg et al., 1998a) and that these must be displayed in a
recise temporal (Rose et al., 1997) and spatial arrangement.
ncrease or decrease of any single one of either the general
r the interaction-specific proteins, either attractive or
epulsive, compromises the specificity of axon targetting.
his implies, however, that the outcome of each guidance
ecision is defined by a precise pattern of expression of a
articular combination of guidance genes. It therefore
eems inescapable that there must be nuclear regulatory
roteins whose function it is to orchestrate the appropriate
xpression of the set of guiding factors, receptors, and
ignaling proteins that together execute the guidance deci-
ions of a given growth cone.
There are two general classes of models that can account
or the coordinated expression of proteins that specify a
uidance decision. It may be that each guidance protein is
egulated independently, such that the overall environment
t an axonal choice point emerges from the summed effects
f many unrelated transcriptional programs. Alternatively,
Copyright © 1999 by Academic Press. All rightt may be that for some guidance decisions there exist a
mall number of “master” regulatory genes, transcription
actors that directly and coordinately control the expression
f multiple guidance genes and thereby ensure that they are
oexpressed at the proper time, place, and relative level.
The gene lola is required for two axon patterning deci-
ions in the developing fly embryo (Seeger et al., 1993;
iniger et al., 1994). In lola mutants, longitudinal axons of
he central nervous system (CNS) fail to grow between
euromeres on a substratum of interface glia, and axons of
he intersegmental nerve (ISN) of the peripheral nervous
ystem fail to grow along the lateral peritracheal cells. In
oth contexts, the identities and differentiation of the
ffected neurons, and of their substratum cells, do not
ppear to be perturbed by the lola mutation, suggesting that
ola is required specifically for the axon/substratum inter-
ction. The lola transcription unit encodes a family of
roducts by use of two promoters and alternative splicing
Giniger et al., 1994). Three major lola transcripts were
dentified by Northern analysis of embryonic RNA, and two
f these, lola 3.8 and lola 4.7, were expressed at times that
ere potentially consistent with a role in the development
f lola-dependent axons. lola 4.7 is preferentially expressed
n the mesoderm, including the substrata and targets of
eripheral axons and is also expressed at somewhat lower
evels in ectodermal derivatives. lola 3.8 is preferentially
xpressed in the ectoderm, particularly in neurons.
The LOLA proteins are transcription factors (Giniger et
l., 1994; Cavarec et al., 1997). Both lola RNAs encode
proteins bearing at their amino terminus a common dimer-
ization domain, known variously as a BTB or POZ domain.
In vitro, BTB domains can mediate both homo- and het-
erodimerization (Bardwell and Treisman, 1994), and the
crystal structure of the BTB domain from the human
protein PLZF reveals the domain to form a tightly inter-
wound structure which is only stable as an oligomer (Ah-
mad et al., 1998). Like many BTB-containing proteins, lola
4.7 also encodes a C-terminal extension bearing two zinc
fingers, suggesting that the protein may bind DNA (Giniger
et al., 1994). This suggestion was confirmed when a protein
was isolated from Drosophila hydei based on its binding
and transcriptional activation of an enhancer in the 59 UTR
of the copia retrotransposon and was found to be the lola
homolog in D. hydei (Cavarec et al., 1997). Subsequent
analysis indeed showed copia expression to be strongly
affected in lola mutant embryos of D. melanogaster. Inter-
estingly, however, whereas copia expression is decreased in
the gonads of lola mutant embryos, suggestive of transcrip-
tional activation by LOLA, copia expression is increased in
mutant CNS, suggestive of transcriptional repression by
LOLA (Cavarec et al., 1997). Perhaps LOLA recruits cell-
type-specific factors which modify its effects on transcrip-
tion, much as some mammalian BTB domains recruit
transcriptional corepressors, including SMRT and N-CoR
(Hong et al., 1997; Huynh and Bardwell, 1998). In contrast
to lola 4.7, lola 3.8 encodes no discernable DNA-binding
motif. Both LOLA isoforms are found in the nucleus.
s of reproduction in any form reserved.
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303lola Coordinates SNb DevelopmentWe now show that lola is required for pathfinding and
target recognition of SNb motor axons in the developing fly
embryo. We then investigate the effect of changing the level
of lola expression in neurons or in target cells and we find
that by varying lola expression we can, in a dose-dependent
ay, titrate the extent of interaction of SNb axons with the
uscles of their target field, from no innervation, through
ild-type patterning, and finally to apparent hyperinnerva-
ion. We suggest that this is the behavior one might predict
or a “master” regulator of SNb neuromuscular interac-
ions.
MATERIALS AND METHODS
Drosophila stocks. lola alleles 5D2 and 1A4 are insertions of
the P-element PlacW and were described by Giniger et al. (1994).
lola alleles c46, e76 and g9 were chemically induced and were
generously provided by Tom Schwarz and Mike Forte; analysis of
the mutant phenotypes and residual LOLA expression in these
three alleles demonstrated that they are strong mutations and that
they produce all the characteristic lola axonal phenotypes (CNS
ongitudinal interruptions, ISN stalling, and failure of SNb inner-
ation; data not shown). GAL4 lines used for expression studies
were twist-GAL4 and GAL4-24b (panmesodermal) and elav-GAL4/
Cyo P[w1; actin-lacZ] (all differentiated neurons). lola overexpres-
sion phenotypes were analyzed in F1 crosses of UAS-lola lines to
AL4-expressing lines; where necessary, embryos were double-
tained with anti-b-galactosidase antibodies to identify lola-
xpressing embryos.
Construction and transformation of UAS-lola transgenes. The
oding sequence of the protein isoform encoded by the lola 4.7
plice variant was subcloned into pUAS-T (Brand and Perrimon,
993) as a 3.9-kb EcoRI fragment from lola cDNA 4.8; the lola 3.8
splice variant was subcloned as a 2-kb EcoRI fragment from cDNA
8.13 (Giniger et al., 1994). DNA was prepared and transformed into
w1118 flies by standard methods, and multiple independent inser-
ions were isolated and balanced. Stocks were prepared that were
omozygous for either one or two copies of each UAS-lola trans-
ene. Western analysis with anti-LOLA antibodies verified that
wo-copy lines expressed more protein than one-copy lines when
rossed to GAL4-producing flies (data not shown). lola overexpres-
ion phenotypes were verified with multiple independent inser-
ions of the UAS-lola transposon.
Antibody staining and analysis. Embryos were collected and
ged on grape juice agar plates at 25°C. Collections of embryos at
2.5–14.5 or 13–15 h were fixed and stained with antibodies by
tandard methods, with detection by peroxidase histochemistry
Vectastain Elite ABC, Vector Labs). The only exception was the
asciclin2/Synaptotagmin double-labelling experiment, for which
uorescent detection was used. Antibodies were as follows: anti-
ven-skipped (1:2), anti-Fasciclin 2 (1:375), and anti-Fasciclin 3
1:2) (Gregg Helt and Corey Goodman); mouse anti-b-gal (1:750,
Boehringer Mannheim); rabbit anti-b-gal (1:10,000, Cappel); mAb
2C10 (1:375) and anti-synaptotagmin (D-syt2; 1:1000) (Hugo
ellen); anti-muscle myosin heavy chain (1:400, Dan Kiehart);
nti-S-59 (1:100, Emma Rushton and Mike Bate); and anti-Toll
1:10, Akira Chiba; and 1:500, Par Towb and Steve Wasserman).
iotinylated and fluorescently conjugated secondary antibodies
ere from Jackson.
Peroxidase-stained embryos were filleted with tungsten needles
Copyright © 1999 by Academic Press. All rightnd mounted in 80% glycerol, or were left intact, dehydrated with
thanol, and mounted as whole mounts in JB4 embedding medium
Polysciences). Samples were examined by Nomarski microscopy
nd photographed with Ilford XP2 film. Negatives were scanned
nd the images stored on a Kodak PhotoCD. Where necessary, focal
lanes were montaged in Photoshop. The phenotypes reported here
ere observed in both filet and whole-mount preparations. Fluo-
escently labelled embryos were mounted in Fluorogard (BioRad)
nd analyzed on an MRC-600 confocal microscope (Keck Center,
niversity of Washington).
Embryos were staged by age, by morphological criteria (particu-
arly gut development, CNS condensation, and onset of cuticle
eposition), and, where possible, by the CNS pattern of Fasciclin 2
mmunoreactivity (by the criteria of Desai and Zinn; described in
he Fly Motor Axon Home Page: http://www.caltech.edu/;zinn/
otoraxons/fma%20home%20page.html). The CNS disruptions
n lola mutant animals prevented us from using the Fasciclin 2
NS pattern for staging. Therefore, samples prepared for analysis of
he lola SNb mutant phenotype were staged using only the first
wo criteria, both for the mutants and for wild-type controls which
ere collected at the same time. anti-Fasciclin 2-stained lola
utant embryos were identified by their distinctive, fully pen-
trant CNS phenotype (Giniger et al., 1994).
RESULTS
lola is required for SNb pathfinding and targeting. As
described in detail by others (Johansen et al., 1989; Sink and
Whitington, 1991; Van Vactor et al., 1993; Landgraf et al.,
1997), SNb motor axons initially exit the CNS through the
root of the intersegmental nerve (ISN) (Fig. 1H). While the
ISN projects dorsally in a relatively superficial trajectory,
SNb axons separate from the ISN just ventral to muscle 28
to dive internally. They then continue projecting dorsally,
between a deeper layer of ventral longitudinal muscles
(VLMs) and a more superficial layer of ventral oblique
muscles (VOMs), with particular axons separating from the
bundle at precise points in the trajectory to innervate
specific target muscles. Because of their clearer visibility in
filleted embyro preparations, we have focussed our analysis
on innervation of the four VLMs that are present in abdomi-
nal segments A2–A7. These are named (from ventral to
dorsal) muscles 7, 6, 13, and 12. The neuromuscular junc-
tions on the VLMs develop in the clefts between adjacent
muscles during embryonic stage 17. Typically, axons infil-
trate the 6/13 cleft first, followed by the 13/12 cleft, and
then 7/6, although this last seems to be the most variable in
timing. By the time of cuticle deposition at late stage 17,
junctional material that is immunoreactive with anti-
Fasciclin 2 antibody is typically visible in at least two, and
often all three of the clefts (Fig. 1A, quantified in Fig. 1E).
Examination of axon patterning in lola mutant embryos
using an antibody against Fasciclin 2 identified a previously
unrecognized lola mutant phenotype. With complete pen-
etrance and very high expressivity, the motor axons that
project through the SNb peripheral nerve failed to form
connections to their cognate muscles (Figs. 1B–1D; quanti-
fied in Figs. 1F and 1G). Most commonly, SNb axons
s of reproduction in any form reserved.
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304 Madden, Crowner, and GinigerFIG. 1. lola is required for SNb development (A–D) SNb morphology in wild-type embryos (A, three hemisegments) or lola mutant
embryos (B–D, two hemisegments each) was visualized by staining stage 17 embryos (13–15 h AEL) with anti-Fasciclin 2 and developing
by peroxidase histochemistry. Stained embryos were filleted and mounted in glycerol; each panel shows a view of the internal surface of
the ventrolateral bodywall (the SNb target field). In these and all other bodywall figures, anterior is to the left and dorsal to the top. (A)
Wild-type embryo. Asterisks indicate positions of VLM neuromuscular junctions (dark, horizontal profiles in the staining). VLMs are
numbered 7, 6, 13, and 12; clefts between adjacent VLMs can be discerned in the Nomarski image and are highlighted with brackets in the
leftmost segment. Peripheral nerves are indicated; SNa, ISN, and TN are typically only dimly visible in the plane of focus of SNb. (B,C) Two
focal planes of a lola1A4 mutant embryo (hypomorphic allele). (B) Focused more internally to show VLM morphology. (C) Focused more
uperficially to show morphology of ventral oblique muscles 30, 14 and 28. SNb (arrows in B) has grown into the cleft between muscles 7
nd 6 in the segment on the right, but has not grown further dorsally in either segment. The VLMs and VOMs (including the more ventral
uscles 15–17, not labeled) are clearly visible in the Nomarski images. Asterisks in C indicate SNb junctions to the underlying VOMs. (D)
ola5D2 mutant embryo (strong allele). The stalled SNbs in these two segments are indicated with arrows; again, the VLMs and VOMs are
visible in the Nomarski image (numbered). (E–G) Expressivity of the lola SNb phenotype. The number of morphologically identifiable SNb
euromuscular junctions to VLMs per hemisegment was scored and presented as a histogram for wild-type and mutant animals. (E)
evelopment of SNb VLM junctions in nonmutant animals (n 5 65). Homozygous balancer embryos and embryos heterozygous for the
alancer over a lola allele were filleted and scored (gray bars). Animals scored were from the same embryo collections used for the mutant
nalysis of F and G. (F) SNb development in lola1A4 embryos (black bars; n 5 29). For comparison, wild-type values from E are shown in gray.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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305lola Coordinates SNb Developmentappeared to “stall” somewhere between the point at which
they would normally separate from the ISN and the muscle
6/13 junction. In other hemisegments, SNb axons projected
through the muscle field but failed to branch into the
intermuscle clefts where synapses should be formed. These
phenotypes were observed in embryos homozygous for
either of two independent lola loss-of-function alleles that
e examined in detail, lola5D2 and lola1A4. We have found
previously that lola1A4 is a hypomorphic allele, based both
n the expressivity of other lola mutant phenotypes and on
he presence of residual LOLA immunoreactivity in ho-
ozygous mutant embryos (K. Madden and E. Giniger,
npublished observations), whereas lola5D2 is a strong allele
Giniger et al., 1994). Consistent with this, we found that
the effect on SNb development is slightly more severe for
lola5D2 than for lola1A4, although most hemisegments are
affected in both alleles. Both lola alleles decrease the
expression of all lola isoforms and appear to have roughly
equivalent effects on lola expression in different tissues
(Giniger et al., 1994; and data not shown). It seems plausible
that the residual SNb development that does occur in
homozygous mutant lola5D2 individuals is due to perdur-
ance of maternally provided protein. We attempted to test
this possibility by generation of homozygous mutant germ-
line clones (using the “dominant female sterile” method),
but failed to recover any embryos from such an experiment
(E. Giniger, E. Grell, S. Younger-Shepherd, and Y. N. Jan,
unpublished). It may be that lola performs some essential
function in the germline during oogenesis.
It does not appear that the lola SNb phenotype can be
explained as resulting from a failure of specification or
overall differentiation of the motoneurons or the muscles.
Previous experiments from us and others have documented
the wild-type expression of molecular markers for many
CNS and PNS cell identities in lola mutant embryos (Seeger
et al., 1993; Giniger et al., 1994). More specifically, the RP3
motoneurons that contribute to SNb can readily be identi-
fied in lola1A4 mutant embryos stained with mAb22C10,
ased on their position, morphology, and initial axon tra-
ectory (Fig. 2A). We confirmed the molecular identities of
hese cells as RP neurons by verifying that they express
asciclin 3 protein (Fig. 2B). Similarly, the VUM motoneu-
ons are also readily identified in lola mutants (not shown).
Since the effects of lola on muscle identity have not
Note the clear shift to fewer neuromuscular junctions per hemisegm
epiction of the SNb target field in embryonic hemisegments A2–A
he most superficial muscle (VOM 28) is in the darkest gray. SNb
ars in the clefts between adjacent VLMs. For clarity, junctions to
any of the figures. Muscle 6 is depicted as if it were lying strictl
o 13, such that the dorsal edge of 6 often extends slightly dorsal
omarski edge will appear parallel but slightly displaced from the i
he only synapse is formed in this cleft). ISN is indicated for comp
e also observed gross defects in the SNa motor nerve in lola mutant em
erve exiting the CNS, suggestive of early defects in its trajectory, so w
Copyright © 1999 by Academic Press. All rightpreviously been analyzed in detail, we characterized muscle
patterning in lola mutants. Perhaps the most stringent and
general assay for muscle identity is the precisely reproduc-
ible pattern of muscle morphologies and attachments in the
developing embryo (Bate, 1990), and for the most part these
appear to be wild type in lola mutants. To further authen-
ticate muscle identities in lola mutant embryos, we sur-
veyed the expression of molecular markers (“founder” and
“progenitor” markers; Fuerstenberg and Giniger, 1998) for
several well-characterized dorsal, lateral, and ventral
muscles. Figure 2C documents the expression of Even-
skipped protein in myoblasts of a stage 13 lola mutant
embryo in the position of the developing dorsal muscle 1
(Landgraf et al., 1999); the inset shows Eve expression
persisting in the corresponding syncitial myotube in a
slightly older embryo. Similarly, in Fig. 2D, expression of
the homeodomain protein S-59 is seen in a stage 13 lola
mutant in the wild-type pattern of four clusters, reflecting
its expression in the developing lateral muscles 5 and 18
(arising from clusters Ia and III, respectively), ventral
muscle 25 (cluster Ib), and ventral muscles 26, 27, and 29
(cluster II) (Carmena et al., 1995). Based on these data, we
infer that muscle identities are not specified by lola. We
note, however, that lola mutant embryos do sometimes
lack one or more of the VLMs. Such defects are substan-
tially less penetrant than is the effect of the mutation on
SNb targeting, but, nonetheless, in quantifying the SNb
phenotypes of lola2 embryos we therefore restricted our
nalysis to hemisegments in which all four VLMs were
resent and had a wild-type morphology (;75–85% of
emisegments).
Finally, it seems unlikely that SNb motor axons simply
ail to reach their peripheral target field as a secondary
onsequence of stalling earlier in their trajectory, at lola-
ependent axonal choice points within the CNS. First, as
escribed above, the SNb axons of lola mutant animals
ypically do reach the target field, and stall only then, when
hey are already in the ventral muscle domain or at its edge.
econd, most of the axons which contribute to SNb do not
ourse through CNS longitudinal nerve segments whose
evelopment depends on lola function (Seeger et al., 1993;
iniger et al., 1994; Landgraf et al., 1997). We note that
VUM-v contributes one axon to SNb (Landgraf et al., 1997),
and we have reported previously that in a modest fraction of
(G) SNb development in lola5D2 embryos (n 5 31). (H) A schematic
he most internal muscles (VLMs) are depicted in the lightest gray;
muscular junctions to the VLMs are depicted as horizontal black
VOMs are not shown in the schematic, though they are visible in
cent to muscle 13; in the embryo it actually lies slightly internal
e ventral edge of 13. Consequently, in some micrographs a faint
ted position of the cleft (which will highlight the edge of 13, where
n; SNa and TN are not shown. In addition to the SNb phenotype,ent.
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arisobryos. However, in many cases we were unable even to detect this
e have not characterized this phenotype further.
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306 Madden, Crowner, and Ginigerhemisegments in lola mutants, the VUM axons fail to
rovide a distinct posterior root to the ISN (Giniger et al.,
994). Careful examination of filleted preparations suggests
hat even in many of these affected hemisegments the VUM
xons do reach the ISN nerve root (albeit via an abnormal
rajectory; data not shown). Moreover, the SNb branch of
UM-v does not form synapses on the VLMs, but rather
nly on the ventral oblique muscles (Landgraf et al., 1997).
Overexpression of lola in muscles causes “hyper-
nnervation.” We reasoned that if lola controls the expres-
ion of one or more guidance genes, then we might gain
nsight into the targets, function, and site of action of lola
y overproducing the protein in various tissues in a wild-
ype genetic background and assaying its effects on SNb
evelopment. Moreover, by performing this experiment
FIG. 2. Neuronal and muscle cell identities are not altered by lola
y peroxidase histochemistry. (A) A lola1A4 embryo; (B–D) lolac46/e
ith mAb 22C10. RP3 is clearly visible in all four hemisegments (
re indicated as anatomical landmarks. (B) A filleted stage 16 lola
ell bodies in two segments; asterisk highlights one RP axon bund
stained with anti-Eve. A cluster of immunoreactive myoblasts is
and labelled DA1 in the figure). Asterisks indicate nearby Eve-po
expression in a syncytial DA1 myotube after myoblast fusion (from
embryo, stained with anti-S-59. Immunoreactivity is clearly detect
(Ia, Ib, II, and III). At this stage, cluster II has begun to split into a
muscle 27, and a ventral portion, which will extinguish S-59 expr
muscle precursor).ith both lola 3.8 and lola 4.7 we hoped to begin distin-
guishing between the functions of these two lola isoforms.
t
b
Copyright © 1999 by Academic Press. All rightWe therefore used the GAL4/UASG expression system
Fischer et al., 1988) to increase the levels of either lola 3.8
r lola 4.7, separately, either in muscles or in differentiated
eurons. We have so far detected no changes in Drosophila
evelopment from altered expression of lola 3.8, and we
ill not consider that isoform further in this report. In
ontrast, altered expression of lola 4.7 was lethal and
aused striking defects in SNb development. Overexpres-
ion of lola 4.7 in all muscles was obtained by crossing flies
hat were homozygous for either one or two copies of a
AS-lola 4.7 transgene to flies bearing the GAL4 enhancer
rap 24b; the phenotype was assayed by collecting stage 17
mbryos, and staining with anti-Fasciclin 2 to visualize
otor axons. GAL4-24b has been extensively characterized
y us and by others, and leads to reporter expression
bryos were incubated with the indicated antibodies and developed
bryos. (A) Dorsal view of a filleted stage 16 lola1A4 CNS, stained
ted as “3”). The prominent motoneurons aCC (“a”) and RP2 (“2”)
, stained with anti-Fasciclin 3. Arrows indicate four labeled RP3
C) Lateral view showing two segments of a stage 13 lola embryo,
ly detected in the position of the developing muscle 1 (bracketed
e pericardial cells (in a slightly different focal plane). (Inset) Eve
lder embryo). (D) Lateral view of two segments from a stage 13 lola
the four clusters typical of the wild-type S-59 expression pattern
al portion, which will continue expressing S-59 and develop into
n and develop into muscles 26 and 29 (and perhaps also an adult. Em
76 em
deno
CNS
le. (
clear
sitiv
an o
ed in
dorshroughout the mesoderm, including all somatic muscles,
ut only in the mesoderm, starting well before the out-
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307lola Coordinates SNb Developmentgrowth of motor axons (Brand and Perrimon, 1993; Fuer-
stenberg and Giniger, 1998).
FIG. 3. Overexpression of lola 4.7 in muscles causes “overgrowth
ot expressed in all muscles were prepared and analyzed by Fascicl
s difficult to quantify, the figure shows three hemisegments from th
lleted, embryos, documenting that muscle morphology is not
mbryos. Note the narrow junctional profiles, largely confined to th
left extends appreciably outside the cleft, and this effect is largely
higher magnification view of one hemisegment from A. Note
rrowhead). (D–F) GAL4-24b/UASG-lola 4.7 (one copy of responder
(filled arrowhead) and of the junctional material and the expansion
by a bracket in some segments). Typically, junctional material i
morphogenesis is not likely to be secondary simply to absence of th
E and F indicate places where SNb has successfully navigated be
improper morphogenesis in these hemisgments does not reflect
between these muscles. (D9) A higher magnification view of one hem
Nomarski image. (G–I). GAL4-24b/2x(UASG-lola 4.7) (i.e., two copies
a larger fraction of embryos. Again, brackets highlight regions of expa
6/13 cleft. We occasionally observe SNb stalling at the 7/6 junction,
junction has also extended anteriorly beyond the edge of the segmenIn embryos that overexpressed lola 4.7 in muscles,
e observed an apparent “overgrowth” of Fasciclin
b
a
Copyright © 1999 by Academic Press. All right-immunoreactive material where SNb axons contacted the
LMs (Fig. 3). Some of this material was in the clefts
SNb neuromuscular junctions. Embryos in which lola 4.7 is or is
staining. Since the phenotype from lola overexpression in muscles
eparate embryos for each genotype. (F, I) Whole mount, rather than
rbed by the dissection protocol. (A–C) GAL4-24b/1 (“control”)
fts between muscles (asterisks in A). Only the junction in the 6/13
icted to the immediate vicinity of the main shaft of the nerve. (A9)
hin SNb nerve shaft extending from one cleft to the next (filled
sgene). Note the thickened profiles of both the main shaft of SNb
nctional material beyond the clefts between muscles (highlighted
o within the cleft, suggesting that the failure of proper junction
ft due to excessive muscle–muscle adhesion. Moreover, arrows in
n muscles 6 and 13 to extend dorsally, again suggesting that the
ple physical barrier preventing the axon from insinuating itself
ment from D. Clefts between successive muscles are visible in the
ponder transgene). Similar phenotypes are observed as in D–F, but in
junctional material and arrows indicate axons navigating beyond the
H (open arrowhead). In this particular instance the neuromuscular
ontinue in the 7/6 cleft in the next more anterior hemisegment.” of
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308 Madden, Crowner, and Ginigercases, broad branches extended over the muscles quite
separate from the normal projections in the clefts. Precise
quantification of the phenotype is difficult because the
classification of individual junctions as either wild type or
abnormal is sometimes ambiguous; however, clearly aber-
rant phenotypes like those in the figure were observed in
approximately 45% of GAL4-expressing embryos bearing
one copy of the UAS-lola transgene and in ;66% of
mbryos bearing two copies of the responder transgene (n 5
4 embryos of each genotype in the experiment shown).
ualitatively similar results were obtained with several
ndependent insertions of the UAS-lola transgene and also
ith a second mesoderm-specific GAL4 driver (twist-
AL4). In addition, at the highest level of expression (with
wo copies of the UAS-lola transgene) we observed very rare
ases where SNb seemed to stall in the ventral part of the
arget field in association with the 6/7 cleft, but where
o axons continued more dorsally to muscles 13 or 12
Fig. 3H).
In some studies of SNb development that have employed
verexpression of transgenes in developing muscles, axonal
efects have been interpreted as arising secondary to defects
n muscle morphogenesis. In particular, it has been sug-
ested that excessive adhesion between adjacent muscles
an physically block the infiltration of SNb axons between
uscles, leading to axon misroutings and misplaced termi-
al arborizations (Nose et al., 1997; Raghavan and White,
997). It seems unlikely that such effects underly most of
he phenotypes we observe. First, we do not observe junc-
ional immunoreactivity to be excluded from the clefts
etween adjacent muscles, but rather to be expanded, with
aterial both in and around the clefts. Morever, we com-
only see an expansion of material at the 6/13 junction,
nd this occurs even in hemisegments where SNb axons
uccessfully penetrate this cleft and continue to muscle 12
Figs. 3E, 3F, and 3I, arrows). Third, a striking feature of the
henotype is expansion of the shaft of the nerve, particu-
arly on muscles 6 and 7, where SNb should have the
arrow caliber typical of a peripheral nerve (Fig. 3, black
rrowheads in 3D9 and 3G9, and Fig. 4) Finally, the clefts
etween the four VLMs are clearly visible morphologically
n lola-overexpressing embryos, both in fillet and in whole-
ount preparations.
In order to test whether the large, Fasciclin
-immunoreactive patches that we observed from lola over-
xpression were likely to be developing presynaptic special-
zations, we double-stained these preparations with anti-
asciclin 2 and with an antibody against a synaptic vesicle
omponent, Synaptotagmin (Fig. 4). We found that the
asciclin 2 immunoreactivity was densely punctuated with
mall foci of intense anti-Synaptotagmin staining that are
ndicative of developing synaptic terminals, and this was
bserved even outside of the clefts where such structures
re typically localized in wild-type animals (Littleton et al.,
993). These data suggest that the expanded Fasciclin 2
mmunoreactivity we observe is likely to reflect expanded
omains of synaptogenesis. We have not yet tested whether
Copyright © 1999 by Academic Press. All righthese expanded domains of axon–muscle contact result in
ncreased synaptic efficacy at the mature neuromuscular
unctions.
Ectopic expression of lola 4.7 in neurons phenocopies
he lola mutant SNb phenotype. We next overexpressed
ola 4.7 in differentiated neurons by crossing flies bearing
ne or two copies of UAS-lola 4.7 to flies carrying elav-
AL4, a well-characterized transgene that leads to GAL4
xpression in all postmitotic neurons, relatively late in
heir differentiation (Luo et al., 1994; Fambrough et al.,
996; Giniger, 1998). We then assayed SNb development by
taining embryos with anti-Fasciclin 2. We observed a
henotype that was strikingly reminiscent of the lola
utant phenotype, with SNb axons failing to innervate the
lefts between adjacent VLMs and often stalling between
he point of separation from the ISN and the muscle 6/13
unction (Figs. 5A–5D). This phenotype was dose-
ependent, occurring at higher frequency when multiple
opies of the UAS-lola transgene were present (quantified
n Figs. 5E–5G). Finally, at the highest levels of expression,
e very occasionally observed a “bypass” phenotype of SNb
xons failing to separate from the ISN altogether (n 5 2/79;
ig. 5D). As was true for the lola mutant phenotype, it is
nlikely that the failure of SNb-VLM interaction in elav-
AL4/UAS-lola embryos is secondary to a failure of the
eurons to differentiate, as we could readily identify the
P3 and VUM motoneurons in such embryos (not shown).
e saw no evidence for defects in muscle morphogenesis in
lav-GAL4/UAS-lola 4.7 embryos.
DISCUSSION
During stage 17 of Drosophila embryogenesis, seven
ventral bodywall muscles become innervated by eight ax-
ons which project through the SNb peripheral nerve. The
genetic mechanisms that match each axon to its specific
target in this system have been studied extensively, perhaps
more so than any other system for analyzing synapse choice
in vivo. Nearly 20 cell surface proteins have been identified
that are expressed on some or all of these muscles, the
incoming growth cones, or both, during the process of target
recognition. For nearly two-thirds of these proteins, genetic
experiments have demonstrated that the protein contrib-
utes to the specificity of target recognition in vivo: an
increase or decrease in protein expression, in appropriate
genetic backgrounds, disrupts the stereotyped matching of
neuron to target. This wealth of data, however, raises a new
and challenging question: what gene regulatory mecha-
nisms maintain the precise balance of all these disparate
positive and negative factors, to ensure that their effects
add-up to specify the precisely reproducible pattern of SNb
innervation?
The transcription factor LOLA is expressed both in the
neurons that project through SNb and in the muscles that
they innervate. We have found that lola is required for the
interaction of SNb axons with the ventral muscles: in the
s of reproduction in any form reserved.
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309lola Coordinates SNb Developmentabsence of lola function, the SNb growth cones reach their
muscle target field, but then stall at about the point where
they should separate from the ISN and begin exploring the
surfaces of the ventral muscles. Moreover, we have found
that by varying the level of expression of one lola isoform,
we can titrate the degree of interaction of SNb axons with
the ventral muscles, from no interaction at all, through
accurate synaptogenesis, to apparent hyperinnervation.
Given the phenotypes induced by both loss- and gain-of-
function manipulations of lola, and the properties of LOLA
protein, the simplest hypothesis is that lola regulates the
transcription of genes that control the interaction of SNb
axons with their target muscles—but which genes? It could
be that lola regulates the expression of just one critical cell
surface protein. However, no gene has been described
whose phenotypes mimic both the loss- and gain-of-
function effects of lola. For example, altered expression of
beat can cause axon stalling at the point of SNb defascicu-
lation, but unlike lola it also causes highly penetrant
“bypass” phenotypes and is not reported to induce ex-
panded terminal arbors (Fambrough and Goodman, 1996).
FIG. 4. Hypertrophied junctional material from lola overexpressio
mbryos were collected and visualized by indirect immunofluo
nti-Synaptotagmin (FITC); colocalization appears yellow. Note
ynaptotagmin at nascent active zones, are observed throughout the
t the positions of intermuscle clefts. In some samples, a low level
n both wild-type embryos and experimental embryos (scattered
oncentrated signals observed in developing synaptic terminals.Moreover, in a wide variety of experimental paradigms,
increases in net adhesion of SNb axons arising from altered
Copyright © 1999 by Academic Press. All rightexpression of single cell surface proteins result in severe
axon misroutings and ectopic contacts to muscles that are
not normally SNb targets (muscles 5 and 8, for example;
Chiba et al., 1995; Krueger et al., 1996; Winberg et al.,
1998a). In contrast, we observe an expanded area of contact
between SNb axons and their proper set of target muscles,
not ectopic projection into nearby inappropriate territories,
and only extremely rare axon misroutings. We note, how-
ever, that we have not yet examined at single-neuron
resolution the fidelity of individual neuron–target contacts
within the SNb target field in embryos that overproduce
lola in muscles.
We speculate that a simpler explanation for the lola
phenotypes may be that lola coordinately regulates the
expression of a number (though not necessarily all) of the
proteins that, together, control the interaction of SNb axons
with the ventral muscles. Thus, in its absence neuron–
muscle recognition fails altogether due to the loss of mul-
tiple axon–target interactions (Bixby et al., 1987; Desai et
al., 1997). Conversely, altering the level of lola expression
in a cell resets the net strength of SNb-VLM interaction by
ntains synaptic vesicle components. GAL4-24b/2x(UASG-lola 4.7)
nce after double-staining with anti-Fasciclin 2 (Texas Red) and
t punctate foci of yellow staining, reflecting concentration of
anded domains of junctional material (white brackets), and not just
nspecific punctate background staining is seen with this antibody
en dots), but this background is easily distinguished from then co
resce
tha
exp
of novarying the absolute levels of a suite of cell surface proteins
made by that cell, but largely maintains their relative
s of reproduction in any form reserved.
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310 Madden, Crowner, and Ginigerlevels. By this view, the misroutings and ectopic axon
contacts observed from altered expression of single cell
FIG. 5. Overexpression of lola 4.7 in neurons phenocopies the lola
in all postmitotic, terminally differentiated neurons were prepared
1. (A) elav-GAL4/1 (“control”) embryo. Arrows indicate the po
dentified by number. (B) elav-GAL4/UASG-lola 4.7 (one copy of re
emisegment shown (thick arrow), other apparent junctions are t
responder transgene). Complete failure of SNb-VLM junction form
lola 4.7) embryo, with micrograph focused at the level of the ISN.
arrow), but displays a “bypass” phenotype in which SNb has failed
though that muscle and the adjacent VOM 14 are visible in the No
4.7 expression on development of SNb–VLM neuromuscular junctio
formation in elav-GAL4/1 (n 5 110). F quantifies elav-GAL4 with
of the responder (n 5 79). Control values are shown in light gray in
declines with increasing lola expression.surface proteins arise from a disturbance in the balance of
factors expressed by each cell (Fambrough and Goodman,
Copyright © 1999 by Academic Press. All right996; Winberg et al., 1998a). For example, it may be that
lola coordinately increases both general factors that pro-
ant phenotype. Embryos in which lola 4.7 is or is not overexpressed
analyzed by Fasciclin 2 staining, as described in the legend to Fig.
s of neuromuscular junctions, and VLM Nomarski profiles are
der transgene). Only a single SNb-VLM junction is formed in each
derlying VOMs. (C) elav-GAL4/2x(UASG-lola 4.7) (two copies of
; arrow indicates stalled SNb (D) A different elav-GAL4/2x(UASG-
is embryo, SNb has formed a junction to one of the VOMs (thick
parate from the ISN by diving under muscle 28 (thin arrow), even
ki image. (E–G) Histograms quantifying the effect of neuronal lola
nalysis is as described in the legend to Fig. 1. E quantifies junction
copy of the UASG-lola responder (n 5 101) and G with two copies
d G. The number of SNb-VLM junctions formed per hemisegmentmut
and
sition
spon
o un
ation
In th
to se
mars
ns. A
onemote overall neuromuscular interaction together with fac-
tors that specifically oppose inappropriate interactions.
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311lola Coordinates SNb DevelopmentTesting this model for lola function will require that we
identify direct transcriptional targets of lola.
The phenotypes we observe from alteration of lola activ-
ity may suggest possible candidates for lola targets. For
xample, reduced SNb innervation can be produced by loss
f beat expression in neurons, as discussed above, or by
verexpression of the repulsive protein Semaphorin 2 in
uscles (Matthes et al., 1995). Conversely, increased inter-
ction of SNb axons with their target muscles could reflect
verproduction of proteins like Fasciclin 3 and Capricious
hat promote neuromuscular interaction, or diminished
xpression of proteins like Toll that limit neuromuscular
nteraction (Rose et al., 1997). Indeed, we have observed
hat in lola2 embryos, Fasciclin 3 immunoreactivity con-
sistently seems less robust than is the case for their non-
mutant siblings (EG, unpublished observations), perhaps
consistent with upregulation of Fasciclin 3 by lola. Addi-
tional experiments will be required, however, to verify and
quantify this apparent effect. Conversely, one protein
whose expression is presumably not strongly affected by
lola is Fasciclin 2: this is the marker we have used to
visualize axon structure in these studies, and we have not
observed obvious differences in Fasciclin 2 levels as we
have altered lola activity. Before we can make strong
predictions about which SNb regulatory proteins are poten-
tial lola targets, however, it will be necessary to determine
whether LOLA activates or represses transcription in these
neurons and muscles. Perhaps we can exploit the identifi-
cation of copia as a direct lola target (Cavarec et al., 1997) to
assay whether LOLA is a positive or negative regulator of
transcription in each of these cells in vivo. We also note
that the direct targets of lola need not be the cell surface
proteins themselves; it is equally possible that lola is part of
a cascade of regulatory proteins.
Since lola is required for SNb-VLM interaction, and
overexpression of lola 4.7 in muscles further increases the
interaction of these cells, it is striking that overexpression
of lola 4.7 in neurons should reduce their interaction. There
are several possible explanations for this apparently para-
doxical result. For example, activation in neurons of a
growth cone-attracting factor may raise axon–axon adhe-
sion excessively and thereby reduce the potential of growth
cones to interact with muscles (Lin and Goodman, 1994).
Alternatively, depending on the transcriptional cofactors
recruited by LOLA in different cells, it may be that LOLA
activates expression of adhesion proteins in muscles, but
represses expression of proteins, perhaps even the same
proteins, in neurons (Cavarec et al., 1997). By either model,
it may be that a key function of lola in neurons is to
enhance neuromuscular specificity by limiting axon–target
interaction (as discussed in the Introduction). Moreover, the
existence of additional lola isoforms provides yet other
possible mechanisms for the varied effects of overproduced
lola 4.7. It is possible, for example, that some of the effect of
overproducing lola 4.7 in neurons arises from titration of
endogenous lola 3.8: while overproduction of lola 3.8 had
no discernable dominant phenotype, this does not exclude
a
h
Copyright © 1999 by Academic Press. All righthe possibility that this isoform may have a positive func-
ion in SNb development in wild-type neurons (where it is
ost highly expressed). Finally, in the initial cloning of lola
e reported the existence of a number of minor RNA
pecies for which no corresponding cDNAs were success-
ully isolated (Giniger et al., 1994). We cannot rule out the
ossibility that there exist as yet uncharacterized lola
soforms which, while present at relatively low abundance
verall, nonetheless play a significant part in lola function
n individual cells and that overproduction of lola 4.7 might
nterfere with their function by formation of nonfunctional
eterodimers or by titration of common cofactors. The
xtreme sensitivity of SNb development to the precise
attern and level of lola expression may also explain why
e have been unable to rescue the lola mutant phenotype
y GAL4-driven expression of single lola isoforms. Our
esults demonstrate that expression of lola even modestly
bove or below the wild-type level, in neurons, substratum
ells, or target cells, leads to severe defects in SNb devel-
pment. Thus, to test definitively which lola isoforms are
ctually required for SNb development, and in which tis-
ues, it will be necessary either to isolate mutant alleles of
ola which are specific for those isoforms and for expression
n those tissues or else to identify fragments of the lola
romoter which can reliably be used to drive expression of
arious lola minigenes in appropriate cells and at precisely
ild-type levels.
In addition to its control of SNb morphogenesis, lola also
egulates growth of CNS longitudinal axons between suc-
essive neuromeres, and growth of ISN axons along lateral
eritracheal cells. It may be that some cell surface proteins
ct in multiple axon growth and guidance decisions, and
hat lola regulates some of the same genes in all three
evelopmental contexts. We note, however, that lola is
xpressed very widely in the nervous system and in the
esoderm and further that lola includes a protein–protein
nteraction motif, the BTB domain, that is found in a large
umber of transcription factors, including many in Dro-
ophila (Zollman et al., 1994). For example, Abrupt is a
TB-containing protein that is expressed in the ventral
uscles and is required for SNb morphogenesis, but is not
equired for other lola-dependent guidance decisions (Hu et
l., 1995). Perhaps LOLA forms different heteromeric com-
lexes with distinct partners in different tissues and
hereby can act in different ways to orchestrate growth cone
unction at different axonal choice points.
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